Tell us about you

Work Email required

Organization required

First Name required

Last Name required

Job Title required

Phone required (###) ###-####, or int ######...

City required

State/Province required

Tell us about your organization

error messages will go here...

Looks like we’re already familiar with you!

Please press next to continue with the survey.

Looks like we’re already familiar with you!

According to your account type you are not eligible to take surveys at this time. If this is a mistake, please contact KLAS.

If you are trying to access KLAS research data and reports, an email has been sent to   with a link to login.

If the email doesn't appear in your inbox, ask your IT department to add KLASresearch.com to your company spam filter's "whitelist", and check your email's spam folder.

Membership Commitment

In exchange for giving their feedback, healthcare providers can create an account to get access to industry reports, user commentary, and real-time ratings.

By submitting your account request, you are engaged in patient care as either an employee (or contractor) of your provider organization and that you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically. To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

Thank You! Your information was submitted successfully!

Next Steps - An email has been sent to . Please follow its instructions to verify your email, and login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank You! Your information was submitted successfully!

Next Steps - A KLAS representative will contact you to discuss working with KLAS, typically within 24 to 48 hours.

If you have any further questions please contact info@klasresearch.com or 1-800-920-4109.

Surprise! Looks like we already have an account for you.

An email has been sent to blah@blah.com with a link to login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Which Imaging Solution is Best for Breast Cancer? - Cover

Which Imaging Solution is Best for Breast Cancer?

Breast cancer is arguably the best-branded medical condition in the United States. One in eight women receive a breast cancer diagnosis during their lifetime, making it the most common cancer worldwide. It stands to reason that patients have become particularly educated regarding this disease.

In our recent conversations with imaging providers regarding their mammography/women’s imaging solutions, providers mentioned that patients have now started to request a tomosynthesis exam by name instead of just calling it 3D mammography or being ignorant about the relatively new process entirely. Clearly, the breast cancer message has been successfully spread.

Traditionally, normal mammography served as the best method for early detection of breast cancer. However its inability to create a 3D image of the breast tissue means that false negatives and positives abound from traditional 2D images. This can result in patients being called in for unneeded return appointments or possibly receiving unnecessary treatment.

While the 3D imaging process of tomosynthesis isn’t a perfect resolution to these concerns, the ability to render an image of the breast tissue in 3D has become critical in assisting providers with diagnosis and patient care. That, in part, explains why 89% of the respondents KLAS interviewed in June said that upgrading to tomosynthesis is a worthwhile investment.

This year, KLAS released the Tomosynthesis 2016 report, designed to help providers understand how the 3 big tomosynthesis vendors (Hologic, GE, and Siemens) compare to one another. Now that all 3 vendors have their 3D mammography solutions FDA approved, it is even more important for you to know which solution best suits your breast cancer imaging needs. 2016 Is Tomosynthesis Worth the Investment?